Janus Henderson Group PLC Mirum Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,581,642 shares of MIRM stock, worth $244 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,581,642
Previous 4,480,284
2.26%
Holding current value
$244 Million
Previous $175 Million
8.42%
% of portfolio
0.1%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$349 Million16.29% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$172 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$149 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$139 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$129 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.95B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...